News roundup [abridged versions appear in the paper journal]

New cholera vaccine is effective among people with HIV

BMJ 2005; 330 doi: 10.1136/bmj.330.7489.438-a (Published 24 February 2005)
Cite this as: BMJ 2005;330:438.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Scott Gottlieb
  1. New York

    A new, orally administered cholera vaccine has been shown to be effective against clinically significant cholera in an urban sub-Saharan population with a high prevalence of HIV infection.

    The results offer one of the best possibilities for improved control of cholera, even among HIV infected people, who may not respond well to other cholera vaccines.

    The results come from an evaluation in Beira, Mozambique—a city where the seroprevalence of HIV is 20% to 30%—of a mass immunisation programme with an oral cholera vaccine consisting of recombinant cholera toxin B subunit and killed whole cells (the rBS-WC vaccine) (New England Journal of Medicine 2005;352:757-67). The World Health Organization …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular